Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility
Cureus · 18.05.2026
DOI: 10.7759/cureus.109091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 18.05.2026. Verfasst von Rubens C Siqueira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Department, Faculdade de Medicina de São José do Rio Preto, Sao Jose do Rio Preto, BRA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Department, Faculdade de Medicina de São José do Rio Preto, Sao Jose do Rio Preto, BRA.
- Immunogenetics Laboratory, Department of Dermatological, Infectious, and Parasitic Diseases, Faculdade de Medicina de São José do Rio Preto, Sao Jose do Rio Preto, BRA.
Zitieren
APA
Siqueira, R. C., Pinho, T. S., & Brandao, C. C. (2026). Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility. Cureus. https://doi.org/10.7759/cureus.109091
Vancouver
Siqueira RC, Pinho TS, Brandao CC. Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility. Cureus. 2026. doi:10.7759/cureus.109091
BibTeX
@article{Siqueira2026,
author = {Siqueira, Rubens C and Pinho, Tainara S and Brandao, Cinara C},
title = {Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109091}
}
EUVIMED